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Progressive Multifocal Leuoencephalopathy(PML) in HIV Patient 
Mohammed MAM Ibnouf1 and Abdalla Hassan Alfaki2. 
Abstract: 
       In the conservative Muslim community’s lack of transparency and awareness to resultant bad 
consequences that mislead practicing doctors, delay in the diagnosis and increase in costs of 
treatment and worsen of morbidity of the disease is the ultimate consequence. Three phases are 
recognized in the natural history of infection by the human immunodeficiency virus (HIV): (a)An 
early or acute phase lasting several weeks with infectious mononucleosis-like symptoms, (b) an 
intermittent or chronic phase, with active low-grade viral replication, lasting several years and (c) 
the final stage or crises, which corresponds to the clinical phase of AIDS. The virus may enter the 
nervous system at the time of sero-conversion. However the clinical picture of dementia appears 
later, when there is marked immunodeficiency. There are many causes for CNS lesions in patients 
with HIV as vascular, viral, bacterial, myco-bacterial, fungal, parasitic, and neoplastic causes. 
Human immunodeficiency virus leucoencephalopathy (HIVL) is an uncommon and rapidly 
progressive form of AIDS dementia complex (ADC) that has remained poorly understood. 
Here we report a rare case of Progressive Multifocal Leuoencephalopathy (PML) in a case of 
HIV/AIDS who was not willing to disclose her diagnosis till late in the disease.   
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 37 year old female, single from 
Hasahisa district was brought to the 
casualty of the Omdurman Military 
Hospital (OMH), suffering of fever and 
headache for four days.   
HPI: A known HIV infected patient, 
diagnosed in Fedail Medical Centre in 2008, 
and was on Highly Active Antiretroviral 
Therapy(HAART) regularly, started in OMH 
several months ago, with the gap period due 
to the social stigma where no one of her first 
degree relatives knows about her disease. She 
used to have prodromal symptoms of flu and 
malaria now and then. When the suffering 
was at its maximum her elder brother insisted 
to bring her seeking medical care. At this 
stage she admitted to have been diagnosed 
and treated as a case of HIV/AIDS.    
She presented complaining of high grade 
fever three days. The fever was associated 
with sweating but not chills, or convulsions. 
Fever was on and off with severe headache 
that prevent her to sleep and associated with 
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nausea and vomiting which was stained with 
bile, 3-4 times a day.  In Hisahisa Hospital, 
she was diagnosed to have malaria and 
received I.M injections, with-out 
improvement   
One day prior to admission the patient 
developed right side weakness and 
drowsiness of sudden onset. She was admitted 
to Hisahisa Hospital in Elgazeera Estate, and 
then referred for brain imaging in Albaraha 
Medical City Khartoum. She developed loss 
of sphincter control, the mother mentioned 
that the right eye and mouth were deviated 
laterally and swallowing became difficult but 
has no other symptoms related to GIT or 
CNS.  
Systemic inquiry: 
Cardio-pulmonary system: no cough, chest 
pain, palpitation, shortness of breath or lower 
limb swelling. 
Genito-urinary system: She has no burning 
micturition or change in urine colour. 
Musculo-skeletal system and skin: no joint or 
bone pain or swelling, but has painful neck 
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Past medical history: She was not known to 
be diabetic or hypertensive, no past similar 
condition. She has no history of 
hospitalization, transfusion or operation 
before. Upper GI endoscopy was performed 
seven months ago for epigastric pain with 
meals. The latter symptoms resolved with 
medications and adjustment of dietary pattern. 
Family history: Her mother is diabetic, no 
hypertension in family, and no similar 
condition. 
Drug history: She was on artimether 
injections for five 5 days and i.v fluid and 
antibiotics the day before admission. 
Social history: moderate socio-economic 
status  
Gynecological history: Mother is not sure 
about it, but her daughter didn’t complain of 
any problem with her cycle.  
Physical examination: On arrival she was 
drowsy. Pulse rate 78beats/minute, regular, of 
average volume, not collapsing, synchronous, 
with palpable distal pulses and normal vessel 
wall. BP 140/80, RR 22 breath/minute, 
temperature 37.8oC. She was not pale, 
jaundiced or cyanosed, but had whitish oral 
ulcerations, JVP was not raised, no thyroid 
enlargement, no cervical lymphadenopathy, 
but she had painful neck stiffness. 
Skin showed generalized macular hyper-
pigmented rash, and some papules with 
crusts. 
Chest and pericordium: normal contour, 
trachea was central, apex beat in 5th Inter 
Costal Space within the Midclavicular line, 
normal air entry, breath sounds and normal 
heart sounds. 
Abdomen: flat, no tenderness, no 
organomegaly.   
CNS: patient was drowsy, not oriented to time 
place or person, with inappropriate sounds. 
However she was co-operative (obeying 
commands) with GCS 13. 
There was weakness in the right lower part of 
the face (upper motor neuron facial palsy) but 
the other cranial nerves possible to examine 
were intact. 
Upper limb examination: average equal 
muscle bulk in both sides, with normal skin. 
The right arm was adducted and medially 
rotated. It was hypertonic and hyperreflexic. 
Lower limb exam: Right limb was externally 
rotated, hypertonic and hyperreflexic with 
bilateral equal average muscular bulk. 
Sphincter control was lost hence she was 
catheterized.  
Investigations: CBC showed normal 
morphology, TWBCs 4.400x109/l,    Hb 10.1 
g/dl,     Platelets 300x109/l.    RBG 64 mg/dl    
ESR 105 in 2 hours,  CD4 count  60×106/l 
blood urea 25mg/dl   creatinine  0.3mg/dl    
K+  3.4mmol/l   Na+ 142mmol/l 
Blood film for malaria was negative. Widal 
test was negative for brucellosis 
Urinalysis:  pus cells   8-10 /HPF    RBCS 15-
17/HPF  albumin +.  
Urine culture and sensitivity showed no 
growth. Chest X-ray showed nothing 
significant. 
Liver Function Test: total proteins 6.2gm\l,                   
albumin 2.1gm\l, globulin 4.1gm\l,                   
Alkaline phosphatase 207 U\l,                   
SGOT 123U\l, SGPT 68U\l,                   
Total billirubin 3mg\dl.  
Antinuclear antibody (ANA) was negative, 
and screening for HIV were strongly reactive 
by ELISA. 
CSF: proteins 400mg\dl, sugar 59mg\dl                            
PCR assay was negative for Mycobacterium 
tuberculosis. 
ECG Showed normal lead pattern. 






Figure1: MRI with pre-ventricularleuco-
encephalopathy.  
 
She was started on I.V, fluid, Mycostatin oral 
drops, antacid syrup, Ceftriaxone 2g 12 
hourly, acyclovir 600mg in normal saline       
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8 hourly and ampiclox 5oo mg q.d.s, 
fluconazole infusion 200 mg b.d. 
Input output fluid chart, and nursing of 
hemiplegic patient. 
Patient discharged three weeks later in a good 
condition with improvement of the higher 
brain functions, motor and cranial nerves 
performance, on HAART, Fluconazole and 
Cefpodoxime to be followed in the referral 
clinic of the(voluntery counceling) VCT in 
OMH. 
Discussion: 
        Although our patient was previously 
diagnosed as HIV/AIDS she did not disclose 
this serious information because of the social 
stigma of this disease in our conservative 
Muslim community though the disease is not 
uncommon (Table 1). 
 
Table 1: HIV/AIDS in Sudan in 2007 
Subject Number Range 
Population, 2008 42,300,000  
Number of people living with HIV 320 000 220 000 - 440 000 
Adults aged 15 to 49 prevalence rate 1.4% 1% - 2% 
Adults aged 15 and up living with HIV 290 000 190 000 - 420 000 
Women aged 15 and up living with HIV 170 000 120 000 - 250 000 
Children aged 0 to 14 living with HIV 25 000 18 000 - 33 000 
Deaths due to AIDS 25 000 17 000 - 32 000 
Orphans due to AIDS aged 0 to 17: Not available Not available 
 
           Source: Epidemiological Fact Sheet on HIV and AIDS, 2008 UNAID
 
HIV enters the nervous system carried in the 
macrophages, and usually infects the 
microglia but not the neurons. The 
physiopathology of dementia is not well 
known. It is thought that neuronal dysfunction 
may be mediated by viral proteins and 
cytokines synthesized by the infected cells 
and toxic to the neurones1. Tumour necrosis 
factor alpha (TNF alpha), which has been 
implicated in the pathogenesis of AIDS 
Dementia Complex (ADC), is localized in 
macrophages in the HIV infected brain2. PML 
is caused by reactivation of latent JC virus in 
the brain. It is the third major cause of focal 
CNS abnormalities in AIDS patients. 
Clinically, there is sub-acute onset of focal 
neurologic deficits with some accompanying 
cognitive decline. Seizures are uncommon3. 
These features are typical of our patient’s 
presentation which was  drowsiness, lack of 
orientation to time place or person associated 
with weakness in the right lower part of the 
face lack of sphincter control, adduction and 
medial rotation of right forearm and flaccid 




PML is primarily a demyelinating disorder 
with a distinctive appearance on MRI (lesions 
confined to subcortical white matter).  
 
Oedema and mass effect are unusual, 
although larger lesions may cavitate. In 
contrast in our patient MRI showed features 
of multi-focal encephalitis with pre-
ventricularleuco-encephalopathy. The sub-
acute presentation in combination with the 
radiologic findings is usually diagnostic. 
Sometimes the polymerase chain reaction 
(PCR) of the spinal fluid for the JC virus is 
helpful in making this diagnosis3. However 
this test is not available in our hospital at the 
time of presentation. 
          There are many potential causes for 
CNS lesions in patients with HIV being 
vascular, viral, bacterial, mycobacterial, 
fungal, parasitic and neoplastic. Vascular 
events include stroke that may occur in 
patients with HIV. Our patient's presentation 
is atypical for that of CNS lesions in HIV-
positive such as CMV encephalitis, PML, or 
HIV. CMV encephalitis should be considered  
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there is evidence of enteritis as well as 
positive finding of CMV in the blood and the 
cerebrospinal fluid. A broad spectrum of 
CMV infection of the CNS includes 
polyradiculitis and periventriculitis, as well as 
mass lesions or abscesses3. However MRI in 
our case did not show the features of CMV. 
On the other hand, PML is caused by 
reactivation of latent JC virus in the brain. It 
is the third major cause of focal CNS 
abnormalities in AIDS patients  
        Bacterial infections may lead to embolic 
or mycotic aneurysms and should be 
considered in patients with history of S. 
aureus pneumonia or anaerobic abscess when 
the patient is febrile and appears toxic. In 
contrast associated cerebro-vascular events 
(stroke or hemorrhage) are common with 
metastatic infection. When these are present, 
MRI shows hypodense centre in the lesion 
associated haemorrhage. Neurosyphilis is a 
bacterial infection that also must be 
considered in patients with HIV since HIV 
accelerates the development of neurologic 
features of syphilis3. Also, Mycobacterium 
tuberculosis must be considered as a cause of 
the brain lesions because CNS infection is 
reported in 5%-10% of patients with HIV and 
tuberculosis3. In addition, fungi must be 
considered as Cryptococcus neoformans, 
Histoplasma-capsulatum, 
Coccidioidesimmitis, however, aspergillus is 
uncommon but recognized opportunist in 
advanced HIV especially with neutropenia, 
high-dose steroids, chemotherapy, 
malignancy, or additional immune 
suppression3. CNS lesions, also, may be 
parasitic such as Toxoplasmosis caused by the 
obligate intracellular protozoan Toxoplasma 
gondii which reactivates, from its latent form, 
in immune compromised patients to cause 
multifocal with predilection for the basal 
ganglia. It appears as enhancing rings 
surrounded by oedema. However CT scan and 
MRI are not sufficient to distinguish the latter 
from primary CNS lymphoma. CNS 
toxoplasmosis with biopsy-proven 
toxoplasmosis may have negative 
Toxoplasma serology4. In contrast, the 
reported frequency of positive serology for 
toxoplasmosis in AIDS was 41% at 30 
months vs 1.9% in seronegative patients. 
However, Raffi et al reported that 97% of 
patients with CNS toxoplasmosis were 
seropositive by enzyme-linked immune-
electro-diffusion assay5. 
             Neoplastic disease should be 
considered as primary CNS lymphoma is the 
most common CNS neoplasm in patients with 
AIDS. Primary CNS lymphoma has a 
subacute presentation, with symptoms 
evolving over weeks but 50% of its victims 
are diagnosed at autopsy. Radiologically, it 
appears as enhancing rings, space-occupying 
masses with associated edema. Although it 
appears pathologically multicentric, there is 
often a single dominant radiologic site. 
Elevated cerebrospinal fluid protein is 
common but cytology is usually negative. 
Progressive multifocal leukoencephalopathy 
(PML) is a rare, deadly demyelinating disease 
of the central nervous system, which is caused 
by a reactivation of the DNA polyomavirus 
JC and occurs in immunosuppressed 
individuals6.  
JCvirus is very common in the general 
population, infecting 70 to 90 percent of 
humans; most people acquire JCV in 
childhood or adolescence7.  
The initial site of JCV infection may be the 
tonsils, or possibly the gastrointestinal tract. 
The virus then remains latent in the 
gastrointestinal tract  and can also infect the 
tubular epithelial cells in the kidneys, where it 
continues to reproduce, shedding virus 
particles in the urine. JCV can cross the 
blood-brain barrier into the central nervous 
system, where it infects oligodendrocytes and 
astrocytes, possibly through the 5-HT2A 
serotonin receptor8.  
    JCV viruria was found as frequently in 
HIV-positive individuals as in control 
subjects, suggesting that its detection has no 
clinical value. JCV detection in the blood 
correlates with immunosuppression and not 
with PML. The presence of JCV in the CSF is 
highly sensitive and specific for PML, and a 
high CSF JC viral load was associated with 
poor clinical outcome in patients receiving 
antiretroviral therapy. JCV quantification in 
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the CSF constitutes a potentially important 
tool for monitoring clinical PML treatment 
trials9. JCV-specific T-cell and IgG responses 
may serve as prognostic markers for patients 
at risk because PML nonsurvivors had 
selectively impaired JCV-specific T-cell 
responses compared to CD4(+) T-cell-
matched controls and failed to mount JCV-
specific antibody responses10.  
Immune reconstitution inflammatory 
syndrome (IRIS) following initiation of 
combined antiretroviral therapy may lead to 
activation of an inflammatory response to 
detectable or latent JC virus infection. Early 
and prolonged treatment with steroids may be 
useful in these patients but requires further 
investigation11.  
There is a strong relationship between PML 
and  monoclonal antibodies (MAbs), 
especially when used in autoimmune diseases. 
PML is becoming a crucial issue of MAbs, 
since they can cause severe  adverse drug 
reaction (ADRs) through the imbalance of the 
immune system. Based on these results, 
patients treated with MAbs should be 
carefully monitored for early signs and 
symptoms of PML12.  
HAART-associated immune reconstitution 
seems to play a role on development of a 
substantial number of PML cases. Although 
the authors could not demonstrate a directly 
deleterious effect of HAART on PML 
progression, prompt initiation of HAART 
after diagnosis of PML and subsequent 
successful response were often associated 
with bad PML outcome13.  
For patients with HIV/AIDS, highly active 
antiretroviral therapy (HAART) is currently 
the only effective therapy for progressive 
multifocal leukoencephalopathy (PML), a 
viral-induced demyelinating disease caused 
by polyomavirus JC. Immune reconstitution 
inflammatory syndrome (IRIS) following 
initiation of HAART can cause paradoxical 
clinical deterioration in patients with 
established PML14.  
Rituximab improves outcomes for persons 
with lymphoproliferative disorders and is 
increasingly used to treat immune-mediated 
illnesses. Awareness is needed of the 
potential for PML among rituximab-treated 
persons15. 
Conclusion:  
HIV is common disease in Sudan. Patient 
may present with neurological features of 
PML. Treating doctors should be transparent 
and raise their patients’ awareness to resultant 
bad consequences of delay the diagnosis that 
lead to increase costs of treatment and worsen 
morbidity of the disease. 
Recommendations:  
PCR assay for Jc virus is recommended to be 
performed in our country to increase 
awareness about the disease and to complete 
the unclear picture of the mechanism and the 
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